TBC1D24 Gene Deafness Autosomal Dominant Type 65 Genetic Test
Welcome to DNA Labs UAE, where we offer comprehensive genetic testing services. Today, we will be discussing the TBC1D24 Gene Deafness Autosomal Dominant Type 65 Genetic Test.
Test Details
The TBC1D24 gene is associated with a form of deafness known as autosomal dominant type 65 (DFNA65). This condition is inherited in an autosomal dominant manner, meaning that an affected individual has a 50% chance of passing the condition on to each of their children.
NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously, providing a comprehensive evaluation of an individual’s genetic makeup. In the context of DFNA65, an NGS genetic test would involve sequencing the TBC1D24 gene to identify any genetic variants or mutations that may be responsible for the condition.
By identifying the specific genetic cause of DFNA65, NGS testing can help with accurate diagnosis, provide information on the inheritance pattern, and guide appropriate management and treatment options. It can also be useful for genetic counseling and family planning purposes.
Test Components and Price
- Test Name: TBC1D24 Gene Deafness Autosomal Dominant Type 65 Genetic Test
- Components: NGS Technology
- Price: 4400.0 AED
Sample Condition
The sample required for this test can be either blood, extracted DNA, or one drop of blood on an FTA card.
Report Delivery
The report for this test will be delivered within 3 to 4 weeks.
Test Type and Doctor
This test falls under the category of Ear Nose Throat Disorders and will be conducted by an ENT Doctor.
Test Department
This test is conducted by our Genetics department.
Pre-Test Information
Prior to undergoing the GJB2 Gene Deafness with keratopachydermia and constrictions of fingers and toes NGS Genetic DNA Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected with GJB2 Gene Deafness with keratopachydermia and constrictions of fingers and toes NGS Genetic DNA Test gene GJB6.
This information will help in obtaining a comprehensive understanding of the patient’s genetic background and aid in accurate diagnosis.
At DNA Labs UAE, we strive to provide the highest quality genetic testing services. Our TBC1D24 Gene Deafness Autosomal Dominant Type 65 Genetic Test can help individuals and families gain insights into their genetic makeup and make informed decisions regarding their health and well-being.
| Test Name | TBC1D24 Gene Deafness autosomal dominant type 65 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Ear Nose Throat Disorders |
| Doctor | ENT Doctor |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for GJB2 Gene Deafness with keratopachydermia and constrictions of fingers and toes NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with GJB2 Gene Deafness with keratopachydermia and constrictions of fingers and toes NGS Genetic DNA Test gene GJB6 |
| Test Details | The TBC1D24 gene is associated with a form of deafness known as autosomal dominant type 65 (DFNA65). This condition is inherited in an autosomal dominant manner, meaning that an affected individual has a 50% chance of passing the condition on to each of their children. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously, providing a comprehensive evaluation of an individual’s genetic makeup. In the context of DFNA65, an NGS genetic test would involve sequencing the TBC1D24 gene to identify any genetic variants or mutations that may be responsible for the condition. By identifying the specific genetic cause of DFNA65, NGS testing can help with accurate diagnosis, provide information on the inheritance pattern, and guide appropriate management and treatment options. It can also be useful for genetic counseling and family planning purposes. |
